Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.48% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WIFI
826
DELISTED
Boingo Wireless, Inc.
WIFI
| $27.3M | 0.02% |
2,495,000
-53,000
| -2% | -$575K |
|
|
CSFL
827
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $27.3M | 0.02% |
1,093,242
-421,700
| -28% | -$10.6M |
|
828
Willis Lease Finance
WLFC
$1.15B
| $27.3M | 0.02% |
1,389,696
+4,200
| +0.3% | +$81.8K |
|
829
CVB Financial
CVBF
$4.08B
| $27.1M | 0.02% |
1,257,094
+11,500
| +0.9% | +$244K |
|
830
TriCo Bancshares
TCBK
$1.86B
| $27.1M | 0.02% |
663,114
-51,224
| -7% | -$1.95M |
|
831
Liberty Media Series A
FWONA
$23.7B
| $27.1M | 0.02% |
645,609
+68,413
| +12% | +$2.69M |
|
|
RST
832
DELISTED
ROSETTA STONE INC
RST
| $27M | 0.02% |
1,488,523
-150,777
| -9% | -$2.57M |
|
833
Myers Industries
MYE
$1.25B
| $27M | 0.02% |
1,616,400
+278,997
| +21% | +$4.64M |
|
834
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.33B
| $26.9M | 0.02% |
246,000
+213,500
| +657% | +$23.1M |
|
835
UFP Technologies
UFPT
$2.48B
| $26.9M | 0.02% |
542,956
+10,700
| +2% | +$467K |
|
836
Kulicke & Soffa
KLIC
$5.01B
| $26.9M | 0.02% |
989,428
-414,100
| -30% | -$10.2M |
|
837
EverQuote
EVER
$864M
| $26.9M | 0.02% |
782,333
+384,877
| +97% | +$10.7M |
|
838
Cavco Industries
CVCO
$4.67B
| $26.9M | 0.02% |
137,509
+17,094
| +14% | +$3.35M |
|
839
Bath & Body Works
BBWI
$3.76B
| $26.7M | 0.02% |
1,824,934
-2,567,835
| -58% | -$37.1M |
|
|
DMC
840
Del Monte Corp
DMC
$1.44B
| $26.7M | 0.02% |
763,300
-292,200
| -28% | -$9.35M |
|
|
AKS
841
DELISTED
AK Steel Holding Corp
AKS
| $26.7M | 0.02% |
8,105,171
+3,065,600
| +61% | +$8.5M |
|
|
CIM
842
Chimera Investment
CIM
$993M
| $26.6M | 0.02% |
431,659
+56,293
| +15% | +$3.43M |
|
843
Tucows
TCX
$134M
| $26.5M | 0.02% |
429,451
-50,400
| -11% | -$2.87M |
|
|
PDLI
844
DELISTED
PDL BioPharma, Inc.
PDLI
| $26.5M | 0.02% |
8,170,631
-1,193,654
| -13% | -$3.47M |
|
|
DNKN
845
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $26.4M | 0.02% |
350,100
+100,100
| +40% | +$7.56M |
|
846
Mitsubishi UFJ Financial
MUFG
$260B
| $26.4M | 0.02% |
4,868,769
+637,044
| +15% | +$3.36M |
|
|
HIBB
847
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $26.4M | 0.02% |
941,577
-225,284
| -19% | -$5.72M |
|
|
NVRO
848
DELISTED
NEVRO CORP.
NVRO
| $26.3M | 0.02% |
+224,100
| New | +$22.2M |
|
849
Washington Trust Bancorp
WASH
$767M
| $26.3M | 0.02% |
489,400
-18,000
| -4% | -$925K |
|
850
RingCentral
RNG
$5.66B
| $26.3M | 0.02% |
155,800
-66,900
| -30% | -$11M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.